Individual InvestorsEmployee ShareholdersInstitutional InvestorsPrivate Companies Accredited Investors Seed & Angel InvestorsAsset Managers & Hedge Funds Family Offices Venture Capital Firms Wealth Managers & RIAsWho We Serve TradingDataLiquidity ProgramsRetirement Individual InvestingForge MarketplaceFind new private company investment opportunitiesBrowse CompaniesInstitutional TradingForge ProTrade private companies with Forge’s institutional brokerage toolForge PriceA proprietary indicative price, calculated daily, for approximately 200 pre-IPO companies Forge DataAnalyze private markets via Forge’s intuitive web applicationForge Private Market IndexMonitor a benchmark for actively traded private companies Forge Accuidity Private Market IndexInvest in an institutionally-managed diversified basket of private companies (QPs only)Liquidity ProgramsRetain and reward employees with company-sponsored liquidity solutions like tender offers and customized programsSelf-Directed IRAForge TrustInvest in private companies and other alternative assets through a tax-advantaged Self-Directed IRAWhat We Do All InsightsReports and highlightsNews and trendsPrivate market educationTips and tutorials Forge Investment Outlook Private Market Updates IPO calendar Private Magnificent 7Emerging trends Private company news Upcoming IPOsPrivate market basics Private shares transactions Valuations, pricing and market trends Selling in the private market FAQs GlossaryCompany page and trades Proof of ownership Bid and ask submissions Forge fund offeringsInsights About Us Leadership Investor Relations People & Culture Careers About

Supira Medical stock

Highest bid

$XXXX

x/xx/xx

Lowest ask

$XXXX

x/xx/xx

Last matched price

$XXXX

x/xx/xx

Forge Price ¹

$--

Buy And Sell Supira Medical StockLearn More About Supira Medical IPOAdd To Watchlist

Supira Medical stock price

Trade metrics

Market activity ²

Limited

Active bids

Active asks

Highest bid price

$ XXX.XX

Lowest ask price

$ XXX.XX

Total bids

$XXX

Total asks

$XXX

Last matched price

$ XXX.XX

xx/xx/xxxx

Last matched valuation

$ XXX.XX

xx/xx/xxxx

Access Stock Price

Price history chart

All

Forge Price

$--

Not yet available

Forge Price valuation

$--

Unlock Trading Activity

Actively traded Healthcare companies

Neuralink

See All Actively Traded Companies

Active market

Explore Market Activity

The image displayed is not current and any securities shown are for illustrative purposes only.

Forge exclusive fund offerings

The image displayed is not current and any securities shown are for illustrative purposes only.

Forge exclusive fund offerings

Access high-growth companies at a fixed price—for a limited time

Invest in trending companies with lower minimums

Simplify private investing through a Forge-managed single company fund

See Available Offerings

Supira Medical stock FAQs

To buy and sell Supira Medical stock

Can you buy Supira Medical stock?

As Supira Medical is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private companies like Supira Medical, you must be an accredited investor. If you meet the accreditation criteria, you can register for Forge to buy private market stock on our secondary marketplace. If you are not accredited, find out how to begin the process and qualify for new investment opportunities.

How to buy Supira Medical stock?

To invest in a private company like Supira Medical through Forge, you must first qualify as an accredited investor. Create your account. Verify your identity and accreditation status to access Forge’s real-time marketplace.

Explore opportunities. Browse companies with active bids and asks, plus data-driven pricing insights like historical trades and Forge Price™.
Submit or negotiate a bid. Place a bid or engage with existing asks—self-directed and fully transparent.
Complete your trade. Forge handles paperwork and approvals, with settlement typically in 45-60 days.

If you’d like additional guidance, Forge private market specialists are available to help.

Can you sell Supira Medical stock?

Yes, as a shareholder, you may be able to sell your Supira Medical shares through Forge’s private market platform—subject to company policies and market interest.

To get started:

Create a Forge account and complete identity and ownership verification.
Submit a sell order (ask) by specifying your desired price, quantity and share class.
Forge will work to match your order with interested buyers in the marketplace.
If a match occurs, Forge coordinates the necessary company approvals and compliance checks, including any transfer restrictions or right of first refusal (ROFR) processes Supira Medical may have in place.

Please note that the ability to complete a transaction depends on Supira Medical’s secondary trading policies, available demand and transaction approvals. While liquidity is not guaranteed, listing your shares on Forge allows you to signal interest and potentially connect with qualified buyers.

How to sell Supira Medical stock?

Create a free Forge account to access Forge’s next generation marketplace
Explore potential demand for your shares and view live market interest
Use proprietary pricing insights and market data to assess timing and valuation
Submit an indication to sell, negotiate terms, complete the transaction and receive your payment

To learn more about Supira Medical stock

Is Supira Medical a public company?

No, Supira Medical is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.

What is Supira Medical’s stock price?

Supira Medical is a privately held company and therefore does not have a public stock price. However, you may access Supira Medical private market stock price with Forge Data.

What is Supira Medical’s stock ticker symbol?

Supira Medical does not have an official ticker symbol because this company is not currently publicly traded.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Supira Medical funding rounds and valuation

Total funding $241.09MM

Funding history chart

Funding round details

	Funding Date	Share Class	Amount Raised	Price Per Share	Post-Money Valuation ³	Key Investors
	03/26/2025	Series E	$120MM	$1.35	$431.99MM	415 Capital, Amed Ventures, Cormorant Asset Management, Novo Holdings, Picard Angst, Qatar Investment Authority, Tcp, Unorthodox Ventures
Price Per Share $1.35 Shares Outstanding 88,757,385 Liquidation Pref Order 1 Liquidation Pref As Multiplier 1.5x Conversion Ratio 1.0x Dividend Rate 8.0% Cumulative Non-cumulative Participating Non-participating Participation Cap -- Key Investors 415 Capital, Amed Ventures, Cormorant Asset Management, Novo Holdings, Picard Angst, Qatar Investment Authority, Tcp, Unorthodox Ventures
	11/21/2023	Series D	$40MM	$1.35	$292.93MM	415 Capital, Amed Ventures, Cormorant Asset Management, Picard Angst, Shifamed Angel Investors, Tcp, Unorthodox Ventures
Price Per Share $1.35 Shares Outstanding 29,585,788 Liquidation Pref Order 2 Liquidation Pref As Multiplier 1.0x Conversion Ratio 1.0x Dividend Rate 8.0% Cumulative Non-cumulative Participating Non-participating Participation Cap -- Key Investors 415 Capital, Amed Ventures, Cormorant Asset Management, Picard Angst, Shifamed Angel Investors, Tcp, Unorthodox Ventures
	02/28/2022	Series C	$30MM	$1.13	$252.17MM	415 Capital, Amed Ventures, Cormorant Asset Management, Picard Angst, Shifamed Angel Investors, Tcp, Unorthodox Ventures
Price Per Share $1.13 Shares Outstanding 26,666,667 Liquidation Pref Order 3 Liquidation Pref As Multiplier 1.0x Conversion Ratio 1.0x Dividend Rate 8.0% Cumulative Non-cumulative Participating Non-participating Participation Cap -- Key Investors 415 Capital, Amed Ventures, Cormorant Asset Management, Picard Angst, Shifamed Angel Investors, Tcp, Unorthodox Ventures
	03/05/2020	Series B	$35.1MM	$0.74	$158.01MM	415 Capital, Amed Ventures, Cormorant Asset Management, Picard Angst, Shifamed Angel Investors, Tcp, Unorthodox Ventures
Price Per Share $0.74 Shares Outstanding 47,432,419 Liquidation Pref Order 4 Liquidation Pref As Multiplier 1.0x Conversion Ratio 1.0x Dividend Rate 8.0% Cumulative Non-cumulative Participating Non-participating Participation Cap -- Key Investors 415 Capital, Amed Ventures, Cormorant Asset Management, Picard Angst, Shifamed Angel Investors, Tcp, Unorthodox Ventures
	06/13/2018	Series A-1	$15.5MM	$0.44	$55.7MM	Cormorant Asset Management, Shifamed Angel Investors, Tcp
Price Per Share $0.44 Shares Outstanding 35,227,261 Liquidation Pref Order 5 Liquidation Pref As Multiplier 1.0x Conversion Ratio 1.0x Dividend Rate 8.0% Cumulative Non-cumulative Participating Non-participating Participation Cap -- Key Investors Cormorant Asset Management, Shifamed Angel Investors, Tcp
	06/13/2018	Series A	$495,000.00	$0.18	$55.7MM	Cormorant Asset Management, Shifamed Angel Investors, Tcp
Price Per Share $0.18 Shares Outstanding 2,750,000 Liquidation Pref Order 5 Liquidation Pref As Multiplier 1.0x Conversion Ratio 1.0x Dividend Rate 8.0% Cumulative Non-cumulative Participating Non-participating Participation Cap -- Key Investors Cormorant Asset Management, Shifamed Angel Investors, Tcp

Company details

Supira Medical is a medical device company that manufactures percutaneous ventricular assist devices (pVADs) designed to give temporary mechanical support to a patient’s heart and allow them to go through required interventional procedures. The devices aim to support patients with coronary artery disease undergoing high-risk percutaneous coronary intervention as well as severe heart attack patients suffering from cardiogenic shock. Supira Medical was founded in 2012 by Nitin Salunke is headquartered in Los Gatos, California.

supiramedical.com

Sector

Healthcare

Subsector

Medical Devices

Founded

2012

Headquarters

Los Gatos, CA, United States

Leadership

Nitin Salunke Ph.D

Chief Executive Officer & President

David Voris

Chief Financial Officer

Janine Robinson

Vice President, Research and Development

Adnan Merchant

Vice President, Systems Engineering

Nicole Haratani

Vice President, Clinical Affairs

Jon Tanaka

Vice President, Operations

Ken Perino

Vice President, Quality

Robert Edesess

Vice President, Intellectual Property

Debbie White

Senior Vice President, Human Resources & Administration

Board

Amr Salahieh

Shifamed

Bihua Chen

Cormorant Asset Management

Casey Gordon

The Capital Partnership

Mariam Maghribi Ph.D

Shifamed

Supira Medical investors also invested in these private compaies

415 Capital

Amed Ventures

Imperative Care, Instylla, Rejoni

Cormorant Asset Management

Aardvark Therapeutics, BioAge, Neurona Therapeutics, Parabilis Medicines, Ensoma, BlossomHill Therapeutics, Alumis, Triveni Bio, Bigfoot Biomedical, Star Therapeutics

Pa Medtech Vc Fund

Myra Vision

Shifamed

Myra Vision

Techlink Ventures

The Capital Partnership

Myra Vision

Unorthodox Ventures

Show More InvestorsShow Fewer Investors

Supira Medical news and media highlights

PR Newswire 03/26/2025

Supira Medical Secures $120M Oversubscribed Series E Financing and Completes Enrollment of SUPPORT I Early Feasibility Study in the United States

Supira Medical, Inc. (Supira), a clinical-stage Shifamed portfolio company, today announced the successful completion of an oversubscribed Series E financing round, raising $120M to accelerate the company's mission of transforming the percutaneous ventricular assist device (pVAD) market.

FinSMEs 11/21/2023

Supira Medical Closes $40M In Series D Financing

Supira Medical, a Los Gatos, CA-based company advancing a percutaneous ventricular assist device (pVAD), raised $40M in Series D funding. The round was led by Cormorant Asset Management and The Capital Partnership (TCP), with participation from 415 CAPITAL, AMED Ventures, PA MedTech VC fund, Unorthodox Ventures and Shifamed angel investors. The company intends to use the funds to expand its currently enrolling OUS studies, plan for its U.S. studies, and prepare for U.S. pivotal study submission.

Browse More Insights

Other companies like Supira Medical in the Medical Devices sector

Sector: Healthcare

Subsector: Medical Devices

Trade Metrics				Last Funding Round
Company		Forge Price	Last Matched Price	Share Class	Post-Money Valuation ³	Price Per Share	Amount Raised
	CMR Surgical	--	$xx.xx	--	--	--	--
	EndoQuest Robotics	--	$xx.xx	Series D-2	$317.11MM	$0.80	$39.66MM
	Levels	--	$xx.xx	Series A-1	$311.7MM	$10.44	$46.01MM
	Neocis	--	$xx.xx	Series D	$320.32MM	$8.66	$112MM
	Neuralink	--	$xx.xx	Series D	$3.49B	$19.03	$323.24MM
	Ottobock	--	$xx.xx	--	--	--	--
	Synchron	--	$xx.xx	Series C	$400.53MM	$27.90	$74.13MM
	Think Surgical	--	$xx.xx	Series D	$291.18MM	$0.33	$84.32MM
	Truvian	--	$xx.xx	Series D-1	$309.02MM	$0.07	$60MM
	Verily Life Sciences	--	$xx.xx	--	--	--	--

See All Companies

Forge is your trusted partner to buy and sell Supira Medical stock

Forge is the trusted platform for buying and selling private company stock. Investors and shareholders worldwide rely on our deep data insights, liquidity solutions, and tailored investment opportunities to navigate the private market. Register to get started.

First time buying private market stock?

New to selling your private company stock?

Updated on: Jul 16, 2025

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Forge Price™ is a custom data-point calculated and disseminated by Forge Data LLC (“Forge Data”) and is a mark of Forge Data. Forge Price may rely on a very limited number of inputs in its calculation. Forge Price is prepared and disseminated solely for informational purposes. Redistribution is permitted solely with Forge’s written consent. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of Forge Price, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of Forge Price. Forge Price is derived from secondary activity on the Forge platform and other private market trading platforms, and other publicly-available datapoints collected by Forge. Forge Price is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Neither reference to company names, nor calculation of Forge Price for a specific company, implies any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company. The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.
Market activity indicates the level of activity for a company based on recent IOIs, secondary transactions, and pending transactions.
Post-Money Valuation represents the estimated valuation based on company-submitted Certificates of Incorporations (COIs).
Last Known Valuation represents a valuation gathered from non-COI, publicly available sources including company press releases or multiple concurring news articles.
Most active companies are companies with a high market activity with the highest post-money valuation in the same sector.

‘Stock Price’ or other private company metrics (‘PC Data’) may rely on a very limited number of trade and/or IOI inputs in their calculation. PC Data is prepared and disseminated solely for informational purposes. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of PC Data, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of PC Data. PC Data is derived from the performance and pricing of secondary activity on the Forge platform and other private market trading platforms. PC Data is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Reference to company names does not imply any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.

The news articles displayed on this page may be curated using artificial intelligence (AI) technology, which selects relevant content from a list of trusted web sources. While we strive for accuracy and reliability, the inclusion of an article does not imply endorsement or verification of its content. This communication is for informational purposes only. Investors should conduct their own research and consult a financial professional before making investment decisions.

Investing in private company securities is not suitable for all investors, is highly speculative, is high risk, and investors should be prepared to withstand a total loss of their investment. Private company securities are highly illiquid and there is no guarantee that a market will develop for such securities. Each investment carries its own risks, and investors should conduct their own due diligence regarding the investment, including obtaining independent professional advice. Past performance is not indicative of future results. This is not a recommendation, offer, solicitation of an offer, or advice to buy or sell securities by Forge, nor an offer of brokerage services in any jurisdiction where Forge is not permitted to offer brokerage services. Brokerage products and services are offered by Forge Securities LLC, a registered broker-dealer and member FINRA/SIPC. Please see other important disclaimers, disclosures and restrictions you acknowledge by using this website and to which you are subject.